Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Keyu Li, Joseph A. Tandurella, Jessica Gai, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1374-1391.e7
Open Access | Times Cited: 94

Showing 26-50 of 94 citing articles:

Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 4
Cancer associated fibroblasts drive epithelial to mesenchymal transition and classical to basal change in pancreatic ductal adenocarcinoma cells with loss of IL-8 expression
Samantha Guinn, Brayan Perez, Joseph A. Tandurella, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Nan Niu, Keyu Li, Jun-Ke Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes
Xiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model
Hiroyuki Inoue, Takayuki Hamasaki, Kazuhiko Inoue, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Association of lung immune prognostic index with overall survival in pancreatic ductal adenocarcinoma patients treated using chemotherapy
Nan Zhang, Guochao Deng, Ru Jia, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 7, pp. 1672-1679
Open Access
Unraveling tumoral heterogeneity and angiogenesis-associated mechanisms of PD-1 and LAG-3 dual inhibition in lung cancers by single-cell RNA sequencing
Lishu Zhao, Chen Tang, Xuan Jin, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2025)
Open Access
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4335-4357
Open Access
PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
Mengdie Cao, Peng Wang, Bin Cheng, et al.
Advanced Science (2025)
Open Access
Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategies
Yi Jin, Eric S. Christenson, Lei Zheng, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 945-958
Open Access | Times Cited: 3
Mitochondrial DNA-boosted dendritic cell-based nanovaccination triggers antitumor immunity in lung and pancreatic cancers
Lihuan Shang, Xue Jiang, Xinbao Zhao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101648-101648
Open Access | Times Cited: 3
The Latest Look at PDT and Immune Checkpoints
David Aebisher, Agnieszka Przygórzewska, Dorota Bartusik‐Aebisher
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7239-7257
Open Access | Times Cited: 3
Multiomics Empowers Predictive Pancreatic Cancer Immunotherapy
Janelle M. Montagne, Elizabeth M. Jaffee, Elana J. Fertig
The Journal of Immunology (2023) Vol. 210, Iss. 7, pp. 859-868
Open Access | Times Cited: 9
Digitize your Biology! Modeling multicellular systems through interpretable cell behavior
Jeanette Johnson, Genevieve Stein-O’Brien, M. Booth, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Converging on a Cure: The Roads to Predictive Immunotherapy
Genevieve Stein-O’Brien, Dung T. Le, Elizabeth M. Jaffee, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1053-1057
Open Access | Times Cited: 7
Factors impacting the benefits and pathogenicity of Th17 cells in the tumor microenvironment
Jie Xing, Changfeng Man, Yingzhao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer
Yongdong Guo, Ronglin Wang, Jingjie Shi, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 9, pp. e007466-e007466
Open Access | Times Cited: 7
The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook
Linh Chi Tran, Berna C. Özdemir, Martin D. Berger
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1411-1411
Open Access | Times Cited: 7
Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy
Hongshuang Shi, Siqi Yu, Wenshi Li, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access | Times Cited: 2
Increased risk of multiple metastases and worse overall survival of metastatic pancreatic body and tail cancer: a retrospective cohort study
Haoqi Zhang, Qingquan Tan, Chengzhi Xiang, et al.
Gland Surgery (2024) Vol. 13, Iss. 4, pp. 480-489
Open Access | Times Cited: 2
Blockade of CCR5+ T Cell Accumulation in the Tumor Microenvironment Optimizes Anti‐TGF‐β/PD‐L1 Bispecific Antibody
Ming Yi, Tianye Li, Mengke Niu, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response
Lili Zeng, Wei Zheng, Jiahui Zhang, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100737-100737
Open Access | Times Cited: 6
Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
Sai Pan, Wenting Zhao, Yizhan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Cancer-associated fibroblasts in neoadjuvant setting for solid cancers
Yanan Gu, Qiangda Chen, Hanlin Yin, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104226-104226
Closed Access | Times Cited: 4

Scroll to top